Compare CIVI & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CIVI | ALVO |
|---|---|---|
| Founded | 1999 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 1.5B |
| IPO Year | 2011 | N/A |
| Metric | CIVI | ALVO |
|---|---|---|
| Price | $27.39 | $5.04 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 4 |
| Target Price | ★ $40.80 | $9.25 |
| AVG Volume (30 Days) | ★ 1.4M | 645.9K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | ★ 7.36% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.86 | 0.24 |
| Revenue | ★ $4,711,808,000.00 | $573,350,000.00 |
| Revenue This Year | N/A | $20.85 |
| Revenue Next Year | N/A | $44.49 |
| P/E Ratio | ★ $3.96 | $20.69 |
| Revenue Growth | N/A | ★ 45.55 |
| 52 Week Low | $22.79 | $4.32 |
| 52 Week High | $55.35 | $13.70 |
| Indicator | CIVI | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | 45.02 |
| Support Level | $26.51 | $4.79 |
| Resistance Level | $28.28 | $5.35 |
| Average True Range (ATR) | 0.91 | 0.30 |
| MACD | -0.14 | 0.04 |
| Stochastic Oscillator | 25.83 | 33.05 |
Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.